Tin t&#x1EE9;c &amp; C&#x1EAD;p nh&#x1EAD;t

Low-dose interleukin 2 (IL-2) therapy may be used to treat moderate-to-severe bullous pemphigoid (BP), as shown by earlier treatment responses of patients in a recent study.

Low-dose IL-2 therapy safe, effective in moderate-to-severe bullous pemphigoid

People with epilepsy face high burden of psychiatric comorbidities

Psychiatric disorders such as anxiety, depression, schizophrenia, autism spectrum disorder, and alcohol dependence, among others, are more prevalent among people with epilepsy than among those who do not have the neurological condition, according to the results of a meta-analysis.

People with epilepsy face high burden of psychiatric comorbidities

Wearable TENS device may zap away pain, fatigue due to long COVID

Daily transcutaneous electrical nerve stimulation (TENS) therapy using a wearable device holds promise in alleviating pain, fatigue, and gait alterations in individuals with long COVID, as shown in a pilot study.

Wearable TENS device may zap away pain, fatigue due to long COVID

Food processing has no association with glycaemic index, load

A recent study has found no difference in glycaemic index (GI) and glycaemic load (GL) between processing levels according to NOVA classification. However, GL is lower in ultraprocessed grains and vegetables than minimally processed foods (MPFs).

Food processing has no association with glycaemic index, load

Low SBP predicts all-cause death in AF patients

Individuals with atrial fibrillation (AF) and a systolic blood pressure (SBP) of <110 mm Hg appear to be at higher risk of all-cause death, suggests a study, noting however that SBP is not significantly associated with renal (dys)function.

Low SBP predicts all-cause death in AF patients

ADA 2022 guidelines improve prescribing rates of SGLT2 inhibitors in T2D patients

The overall utilization rates of SGLT2 inhibitors have increased among patients with type 2 diabetes (T2D) following the release of the 2022 American Diabetes Association (ADA) guidelines.

ADA 2022 guidelines improve prescribing rates of SGLT2 inhibitors in T2D patients

02 Dec 2024

Beer drinkers have it worse diet-wise than other alcohol drinkers

Among consumers of different types of alcohol, those who consume beer only have the lowest dietary quality compared with those confined to wine or liquor intake or those who consume multiple types of alcohol, according to data presented at TLM 2024.

Beer drinkers have it worse diet-wise than other alcohol drinkers

S1PR1 agonist a promising treatment for rheumatoid arthritis

The selective agonist of sphingosine-1-phosphate receptor-1 (S1PR1), proximod, appears to be well tolerated and helps reduce blood lymphocyte count in patients with rheumatoid arthritis (RA), according to a phase I study.

S1PR1 agonist a promising treatment for rheumatoid arthritis

7 days of antibiotics as effective as 14 days for bloodstream infections

In the noninferiority BALANCE* trial, 7 days of antibiotic use is as effective as 14 days for treating bloodstream infections (BSIs) in hospitalized patients, drawing renewed interest from clinicians attending IDWeek 2024.

7 days of antibiotics as effective as 14 days for bloodstream infections